Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if treatment with testosterone will reduce abdominal fat
in HIV-positive men.
Many HIV patients on antiretroviral therapy show an increase in abdominal fat. Studies have
shown that treatment with testosterone may decrease abdominal fat. This study will determine
if testosterone will reduce abdominal fat in HIV patients.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)